Trial intelligence / Profile preview

MELATOX: Melatonin cream as sunscreen in healthy volunteers

NCT02224937Phase 1Completed

Sponsor
Zealand University Hospital
Start
Dec 2013
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of melatonin in photoaging, sponsored by Zealand University Hospital. Primary endpoint: Karolinska Sleepiness Scale at 36 hours. Started Dec 2013; status: completed.

02

Drugs

melatonin
03

Conditions

photoaging

Beyond the preview

Go deeper on NCT02224937.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02224937.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call